Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging.
Muhammad Talha AyubDinesh K KalraPublished in: Diagnostics (Basel, Switzerland) (2020)
Patients with coronary microvascular dysfunction (CMD) have significantly higher rates of cardiovascular events, including hospitalization for heart failure, sudden cardiac death, and myocardial infarction (MI). In CMD, several pathophysiological changes lead to functional and structural abnormalities in the coronary microvasculature, which disrupt the ability of the vessels to vasodilate and augment myocardial blood flow in response to increased myocardial oxygen demand, causing ischemia and angina. With the advent of more advanced non-invasive cardiac imaging techniques, the coronary microvasculature has been subjected to more intense study in the past two decades-this has led to further insights into the diagnosis, pathophysiology, treatment, prognosis and follow-up of CMD. This review will highlight and compare the salient features of the currently available non-invasive imaging modalities used in these patients, and discuss the clinical utility of these techniques in the workup and management of these patients.
Keyphrases
- coronary artery disease
- coronary artery
- heart failure
- cardiovascular events
- end stage renal disease
- left ventricular
- ejection fraction
- blood flow
- high resolution
- newly diagnosed
- chronic kidney disease
- aortic stenosis
- prognostic factors
- peritoneal dialysis
- oxidative stress
- cardiovascular disease
- percutaneous coronary intervention
- patient reported outcomes